Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.
4.

Cytologic evaluation of cyclin D1 expression in primary breast carcinoma.

Park K, Han S, Kim HY, Ko I.

Cancer. 2001 Jun 25;93(3):211-5.

PMID:
11391609
5.

Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.

McDonald JW, Pilgram TK.

Histopathology. 1999 May;34(5):439-46.

PMID:
10231419
6.

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.

Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.

Cancer. 2004 Jun 1;100(11):2367-75.

7.

Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.

Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.

Arch Med Res. 2007 Nov;38(8):846-52. Epub 2007 Aug 2.

PMID:
17923265
8.

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10.

PMID:
11286838
9.

p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.

Rey MJ, Fernández PL, Jares P, Muñoz M, Nadal A, Peiró N, Nayach I, Mallofré C, Muntané J, Campo E, Estapé J, Cardesa A.

J Pathol. 1998 Mar;184(3):265-71.

PMID:
9614378
10.
11.

Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.

Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A.

Mod Pathol. 1995 Jun;8(5):560-7.

PMID:
7675778
12.

p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas.

Gimenez-Conti IB, Collet AM, Lanfranchi H, Itoiz ME, Luna M, Xu HJ, Hu SX, Benedict WF, Conti CJ.

Cancer. 1996 Jul 1;78(1):17-23.

13.
14.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
15.

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.

Lebeau A, Unholzer A, Amann G, Kronawitter M, Bauerfeind I, Sendelhofert A, Iff A, Löhrs U.

Breast Cancer Res Treat. 2003 May;79(2):187-98.

PMID:
12825853
16.

Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.

Caffo O, Doglioni C, Veronese S, Bonzanini M, Marchetti A, Buttitta F, Fina P, Leek R, Morelli L, Palma PD, Harris AL, Barbareschi M.

Clin Cancer Res. 1996 Sep;2(9):1591-9.

18.

Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N.

Croat Med J. 2008 Oct;49(5):643-9.

19.

Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer.

Iwaya K, Tsuda H, Fukutomi T, Tsugane S, Suzuki M, Hirohashi S.

Jpn J Clin Oncol. 1997 Feb;27(1):6-12.

PMID:
9070333
20.

Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.

Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2247-51.

Supplemental Content

Support Center